Fleury, I., and E. Laverdure. “Bispecific Antibodies and Chimeric Antigen Receptor (CAR) T-Cell Therapy for Indolent Lymphoma”. Canadian Hematology Today, vol. 2, no. 3, Nov. 2023, pp. 5-11, doi:10.58931/cht.2023.2338.